Australia markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
69.39+0.79 (+1.15%)
At close: 04:00PM EDT
69.49 +0.10 (+0.14%)
After hours: 07:57PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
8,344,000
8,344,000
4,311,000
8,001,000
7,179,000
Depreciation & amortisation
4,366,000
4,366,000
4,224,000
4,486,000
4,441,000
Deferred income taxes
-676,000
-676,000
-2,029,000
-402,000
-570,000
Stock-based compensation
588,000
588,000
447,000
484,000
400,000
Change in working capital
15,000
15,000
6,818,000
3,857,000
3,159,000
Accounts receivable
-6,260,000
-6,260,000
-2,971,000
-2,703,000
-1,510,000
Inventory
1,233,000
1,233,000
-1,435,000
735,000
-973,000
Accounts payable
3,618,000
3,618,000
4,260,000
2,898,000
2,769,000
Other working capital
10,395,000
10,395,000
13,450,000
15,745,000
13,428,000
Other non-cash items
416,000
416,000
332,000
-390,000
72,000
Net cash provided by operating activities
13,426,000
13,426,000
16,177,000
18,265,000
15,865,000
Cash flows from investing activities
Investments in property, plant and equipment
-3,031,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
Acquisitions, net
-16,612,000
-16,612,000
-1,388,000
-146,000
-866,000
Purchases of investments
-9,043,000
-9,043,000
-7,746,000
-9,963,000
-9,639,000
Sales/maturities of investments
7,729,000
7,729,000
6,729,000
7,246,000
6,467,000
Other investing activities
68,000
68,000
85,000
122,000
-
Net cash used for investing activities
-20,889,000
-20,889,000
-5,047,000
-5,261,000
-5,534,000
Cash flows from financing activities
Debt repayment
-8,166,000
-8,166,000
-4,211,000
-10,254,000
-15,631,000
Common stock repurchased
-2,012,000
-2,012,000
-3,500,000
0
-
Dividends paid
-3,132,000
-3,132,000
-2,907,000
-2,625,000
-2,624,000
Other financing activities
-382,000
-382,000
-449,000
-13,000
337,000
Net cash used provided by (used for) financing activities
2,683,000
2,683,000
-10,516,000
-11,356,000
-7,696,000
Net change in cash
-4,780,000
-4,780,000
614,000
1,648,000
2,635,000
Cash at beginning of period
13,305,000
13,305,000
12,691,000
11,043,000
8,408,000
Cash at end of period
8,525,000
8,525,000
13,305,000
12,691,000
11,043,000
Free cash flow
Operating cash flow
13,426,000
13,426,000
16,177,000
18,265,000
15,865,000
Capital expenditure
-3,031,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
Free cash flow
10,395,000
10,395,000
13,450,000
15,745,000
13,428,000